Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in SpainJuan Berenguer, Pablo Ryan, María Yllescas et al.|Clinical Microbiology and Infection|2020Cited by 423
Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)Jesús Rodríguez‐Baño, María Paz García Butenegro, Elena Trigo Esteban et al.|Clinical Microbiology and Infection|2020Cited by 128
Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort studyBelén Gutiérrez‐Gutiérrez, Chiara Fanciulli, Alberto M. Borobia et al.|The Lancet Infectious Diseases|2021Cited by 104
Epidemiological trends of HIV/HCV coinfection in Spain, 2015–2019Chiara Fanciulli, Juan Berenguer, Carmen Busca et al.|HIV Medicine|2022Cited by 28
Switching to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) plus darunavir/cobicistat in heavily antiretroviral-experienced, virologically suppressed HIV-infected adults receiving complex regimensDaniel Podzamczer, Antonio Rivero, Arkaitz Imaz et al.|Journal of Antimicrobial Chemotherapy|2023Cited by 10